121 related articles for article (PubMed ID: 32926164)
1. Rapid Molecular Detection for Differentiation of Homozygous HbE and ß0-Thalassemia/HbE in Samples Related With HbE >80% and Variable HbF Levels.
Tepakhan W; Jomoui W
Lab Med; 2021 May; 52(3):232-239. PubMed ID: 32926164
[TBL] [Abstract][Full Text] [Related]
2. EE score: an index for simple differentiation of homozygous hemoglobin E and hemoglobin E-β0-thalassemia.
Singha K; Fucharoen G; Sanchaisuriya K; Fucharoen S
Clin Chem Lab Med; 2018 Aug; 56(9):1507-1513. PubMed ID: 29668441
[TBL] [Abstract][Full Text] [Related]
3. Detection of beta-thalassemia/hemoglobin E disease in samples which initially were diagnosed as homozygous hemoglobin E.
Pornprasert S; Moriyama A; Kongthai K; Waneesorn J; Jaiping K; Treesuwan K; Hattori Y
Clin Lab; 2013; 59(5-6):693-7. PubMed ID: 23865372
[TBL] [Abstract][Full Text] [Related]
4. Molecular understanding of unusual HbE-β
Jomoui W; Satthakarn S; Panyasai S
Ann Med; 2023; 55(2):2267054. PubMed ID: 37816374
[TBL] [Abstract][Full Text] [Related]
5. Measurement of HbA₂ by capillary electrophoresis for diagnosing β-thalassemia/HbE disease in patients with low HbF.
Prasing W; Pornprasert S
Lab Med; 2014; 45(3):226-30. PubMed ID: 25051074
[TBL] [Abstract][Full Text] [Related]
6. A Formula to Identify Potential Cases of β-Thalassemia/HbE Disease Among Patients With Absent HbA, HbE >75% and HbF Between 5 and 15.
Pornprasert S; Tookjai M; Punyamung M; Kongthai K
Lab Med; 2019 Apr; 50(2):158-162. PubMed ID: 30239825
[TBL] [Abstract][Full Text] [Related]
7. HbF in HbE/β-thalassemia: A clinical and laboratory correlation.
Lim WF; Muniandi L; George E; Sathar J; Teh LK; Lai MI
Hematology; 2015 Jul; 20(6):349-53. PubMed ID: 25243862
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA expression patterns in HbE/β-thalassemia patients: The passwords to unlock fetal hemoglobin expression in β-hemoglobinopathies.
Das SS; Das S; Byram PK; Rahaman M; Dolai TK; Chatterjee A; Chakravorty N
Blood Cells Mol Dis; 2021 Mar; 87():102523. PubMed ID: 33242839
[TBL] [Abstract][Full Text] [Related]
9. Analysis of the Xmn1-(G) γ polymorphism in β-thalassemia/hemoglobin E (HbE) and homozygous HbE patients with low and high levels of HbF.
Prasing W; Odawara T; Traisathit P; Yamashiro Y; Hattori Y; Pornprasert S
Int J Lab Hematol; 2015 Apr; 37(2):e25-8. PubMed ID: 25043956
[No Abstract] [Full Text] [Related]
10. Screening for co-existence of α-thalassemia in β-thalassemia and in HbE heterozygotes via an enzyme-linked immunosorbent assay for Hb Bart's and embryonic ζ-globin chain.
Tatu T; Kiewkarnkha T; Khuntarak S; Khamrin S; Suwannasin S; Kasinrerk W
Int J Hematol; 2012 Apr; 95(4):386-93. PubMed ID: 22438184
[TBL] [Abstract][Full Text] [Related]
11. The molecular basis of beta-thalassemia intermedia in southern China: genotypic heterogeneity and phenotypic diversity.
Chen W; Zhang X; Shang X; Cai R; Li L; Zhou T; Sun M; Xiong F; Xu X
BMC Med Genet; 2010 Feb; 11():31. PubMed ID: 20181291
[TBL] [Abstract][Full Text] [Related]
12. Analysis of Gγ-158(C→T) polymorphism in hemoglobin E/β-thalassemia major in Southern China.
Liu RR; Wang MY; Lai YR
J Hematol Oncol; 2010 Sep; 3():29. PubMed ID: 20822527
[TBL] [Abstract][Full Text] [Related]
13. Genetic variation of Krüppel-like factor 1 (KLF1) and fetal hemoglobin (HbF) levels in β
Khamphikham P; Sripichai O; Munkongdee T; Fucharoen S; Tongsima S; Smith DR
Int J Hematol; 2018 Mar; 107(3):297-310. PubMed ID: 29067594
[TBL] [Abstract][Full Text] [Related]
14. β-Hemoglobinopathies in the Lao People's Democratic Republic: Molecular diagnostics and implication for a prevention and control program.
Singha K; Chaibunruang A; Souvanlasy B; Srivorakun H; Yamsri S; Fucharoen G; Fucharoen S
Int J Lab Hematol; 2021 Jun; 43(3):500-505. PubMed ID: 33244864
[TBL] [Abstract][Full Text] [Related]
15. Modifying effect of XmnI, BCL11A, and HBS1L-MYB on clinical appearances: A study on β-thalassemia and hemoglobin E/β-thalassemia patients in Indonesia.
Rujito L; Basalamah M; Siswandari W; Setyono J; Wulandari G; Mulatsih S; Sofro AS; Sadewa AH; Sutaryo S
Hematol Oncol Stem Cell Ther; 2016 Jun; 9(2):55-63. PubMed ID: 27009595
[TBL] [Abstract][Full Text] [Related]
16. Molecular prevalence of thalassemia and hemoglobinopathies among the Lao Loum Group in the Lao People's Democratic Republic.
Phanmany S; Chanprasert S; Munkongdee T; Svasti S; Leecharoenkiat K
Int J Lab Hematol; 2019 Oct; 41(5):650-656. PubMed ID: 31271507
[TBL] [Abstract][Full Text] [Related]
17. The hemoglobin E syndromes.
Rees DC; Styles L; Vichinsky EP; Clegg JB; Weatherall DJ
Ann N Y Acad Sci; 1998 Jun; 850():334-43. PubMed ID: 9668555
[TBL] [Abstract][Full Text] [Related]
18. Nationwide carrier detection and molecular characterization of β-thalassemia and hemoglobin E variants in Bangladeshi population.
Noor FA; Sultana N; Bhuyan GS; Islam MT; Hossain M; Sarker SK; Islam K; Khan WA; Rahman M; Qadri SK; Shekhar HU; Qadri F; Qadri SS; Mannoor K
Orphanet J Rare Dis; 2020 Jan; 15(1):15. PubMed ID: 31941534
[TBL] [Abstract][Full Text] [Related]
19. Genetic determinants related to pharmacological induction of foetal haemoglobin in transfusion-dependent HbE-β thalassaemia.
Biswas S; Nag A; Ghosh K; Ray R; Roy K; Bandyopadhyay A; Bhattacharyya M
Ann Hematol; 2019 Feb; 98(2):289-299. PubMed ID: 30413899
[TBL] [Abstract][Full Text] [Related]
20. Hematological parameters in combination with HbF levels are appropriate for screening of beta-thalassemia/HbE disease with HbF varying from 5 to 15%.
Pornprasert S
Clin Lab; 2014; 60(8):1422. PubMed ID: 25185434
[No Abstract] [Full Text] [Related]
[Next] [New Search]
